MICA and hepatocellular carcinoma: In conclusion, we have shown that in patients with HCC, the altered NK function caused by the impaired NKG2D-MICA/B interaction, could be restored by IL-15 stimulation associated with a humanized anti-MICA/B-specific mAb that efficiently mediates ADCC in vitro.